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Summary 
Biofunctional peptide ingredients should retain their stability following standard processing operations in 
food-based delivery vehicles. A boarfish protein hydrolysate, exhibiting anti-diabetic activity was 
subjected to a range of thermal treatments following incorporation into tomato-based soup and juice 
products. The dipeptidyl peptidase-IV (DPP-IV) inhibitory activity and peptide profile of the hydrolysate 
within the products were assessed before and after thermal treatment. The treatments applied had no 
effect on the DPP-IV inhibitory activity or peptide profile of the protein hydrolysate. The heat-treated 
(90°C x 1 min and 121°C x 42 s) juice-fortified beverage had microbial counts within the acceptable limits 
for consumption when stored at 4°C for 30 days. Furthermore, the hydrolysate within the beverage 
products was resistant to simulated gastrointestinal digestion (SGID) regardless of whether it was heat or 
non-heat treated, or stored for 30 days at 4°C. Therefore, tomato-based beverages are suitable delivery 
vehicles for biofunctional peptide ingredients. 
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1. Introduction
There is an established consumer demand and a rapidly growing market for foods and/or food ingredients 
which provide health benefits beyond their basic nutritional properties, i.e., functional foods. Food 
proteins contain a diverse array of short peptides (2-20 amino acids) which are released during food 
processing (by enzymatic hydrolysis or fermentation) or during gastrointestinal transit with the potential 
to beneficially modulate human health (Harnedy & FitzGerald, 2012 & 2013). Protein hydrolysates or 
peptides mediating such properties have potential applications as functional food ingredients. The 
selection of an appropriate food vehicle for delivery of a functional ingredient is of major importance as 
foods contain many components that can interact with peptides and mediate a reduction in peptide 
bioactivity and bioavailability (Kamdem & Tsopmo, 2019). Furthermore, one of the primary challenges 
associated with the incorporation of bioactive peptides into commercial products is the susceptibility of 
the peptides to modification during conventional food processing operations, e.g., thermal treatment. 
Due to its ability to inactivate microorganisms and spoilage enzymes thermal treatment is the most 
commonly used processing operation in the food industry (Rawson et al., 2011). Thermal treatment of 
protein/peptide containing foods may induce substantial changes in the structure of the protein or 
protein hydrolysate. These include protein/peptide denaturation or aggregation, interactions between 
protein/peptide/amino acids and other components within the food matrix e.g., the generation of 
Maillard reaction products, destruction of heat sensitive amino acids and the formation of 
dehydroalanine-derived cross-links (Singh, 1991; Korhonen et al., 1998; Gerrard, 2002; Vasbinder et al., 
2003; Rao et al., 2016).  
To date, information regarding the influence of routinely used industrial processing and storage 
conditions on the bioactivity, in particular the potential anti-diabetic activity, of protein hydrolysates 
when incorporated into different food matrices is limited. The majority of the research reported to date in 
this area has been performed with aqueous solutions of protein hydrolysates/peptides and not with 
delivery vehicles containing the functional protein hydrolysate/peptide ingredient (Hwang, 2010; Wu et 
al., 2014; Zhu et al., 2014; Lai et al., 2016; Wali et al., 2017; Rivero-Pino et al. 2020). 
In a previous study we have shown that a boarfish-derived protein hydrolysate (BPH) exhibits promising 
anti-diabetic activity both in vitro (DPP-IV inhibition and pancreatic β cells and enteroendocrine cells in 
culture) and in a small animal study (Parthsarathy et al., 2019). While the hydrolysate had no effect on 
biomarkers of glycaemic control and satiety at the dose given in a randomised controlled human 
intervention crossover study with healthy adults, a significant increase in satiety rating was reported at 
180 min following consumption of a beverage fortified with the hydrolysate compared to the unfortified 
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2) DPP-IV inhibitory activity and in situ insulin secretory activity have been identified within the BPH  
(Harnedy-Rothwell et al., 2020). Based on the above results the BPH has potential applications as an 
antidiabetic functional food ingredient. 
In order for protein hydrolysates to be utilised as functional food ingredients they must retain their 
activity when incorporated into food matrices which experience various processing and storage 
conditions. Therefore, this study determined the effect of thermal treatment (pasteurisation and 
sterilisation) and storage conditions on the in vitro dipeptidyl peptidase-IV (DPP-IV) inhibitory activity of a 
BPH when incorporated into two tomato-based products (a soup and a beverage). Furthermore, the effect 
of fortification of a tomato-based matrix, heat treatment and storage conditions on the susceptibility of 
the BPH to simulated gastrointestinal digestion (SGID) was investigated.
2. Materials and methods 
2.1. Materials and chemicals
H-Gly-Pro-7-amino-4–methyl coumarin (AMC) and Diprotin A were obtained from Bachem 
Feinchemikalien (Bubendorf, Switzerland). Kjeldahl catalyst tablets were obtained from VWR International 
(Dublin, Ireland). Low nitrogen sodium hydroxide (40% (w/v)) was obtained from TE Laboratories Ltd. 
(Carlow, Ireland). Sulphuric acid (low nitrogen) was purchased from Lennox Laboratory Supplies Ltd 
(Dublin, Ireland). Corolase PP was provided by AB Enzymes (Darmstadt, Germany) and BC pepsin was 
kindly provided by Biocatalysts Ltd (Cardiff, Wales, United Kingdom). All other reagents including 
Alcalase® 2.4L and Flavourzyme® 500L and DPP-IV, from porcine kidney (≥10 units/mg protein) were 
supplied by Sigma Chemical Company Ltd. (Wicklow, Ireland). Samples of minced deboned boarfish 
(Capros aper) meat was kindly provided by Bio-Marine Ingredients Ireland, Ltd., Lough Egish Food Park, 
Castleblaney, Co. Monaghan, Ireland. A tomato based chilli soup, containing tomatoes, red peppers, red 
chillies and chilli flakes, garlic, olive oil, fresh basil and vegetable stock was prepared at Ulster University, 
Coleraine, Co. Derry, Northern Ireland.
2.2. Generation of BPH at semi-pilot scale 
The BPH was generated with Alcalase 2.4L and Flavourzyme 500L at semi-pilot scale as described 
previously (Harnedy-Rothwell et al., 2020). 
2.3 Quantification of protein equivalent content 
The protein equivalent content of the BPH was measured by the macro-Kjeldahl procedure (Connolly et 









This article is protected by copyright. All rights reserved
2.4. Preparation, processing and storage of tomato soup and juice products and control samples.
Tomato based chilli soup samples with (5.83% (w/w)) and without BPH were prepared. An equivalent 
aqueous solution of the hydrolysate was also prepared (e.g., 5.83 % (w/w)) at pH 5.26) and used as a 
control. The samples containing the hydrolysate were heated at 80 and 95 oC for 3 min and at 121 oC for 
42 s (sterilisation conditions) in an oil bath and were then rapidly cooled by placing on ice (Gould, 1992). A 
second set of samples which received no heat treatment was also prepared.
V8® vegetable juice (Kelsen A/S Group, Denmark) was purchased from a health food shop (Limerick, 
Ireland). Vegetable juice samples with and without BPH (2.33% (w/v) powder equivalent to 1.64% (w/v) 
protein/hydrolysate) were prepared. An equivalent aqueous solution containing the hydrolysate was also 
prepared (e.g., 2.33% (w/w) and pH 4.71) and used as a control. The samples containing the hydrolysate 
were heated at 90 oC for 1 min (pasteurisation conditions) and 121 oC for 42 s (sterilisation conditions) in 
an oil bath and then rapidly cooled by placing on ice (Gould, 1992). Samples were stored for 30 days at 4 
oC and were subsampled on Day 0, 1, 3, 7, 10, 15, 20, 25 and 30. A second set of samples, which received 
no heat treatment (and which were not stored for 30 days at 4 oC) were also prepared to investigate the 
effect of heat treatment on the DPP-IV inhibitory activity and peptide profile of the hydrolysate on Day 0. 
2.5. Simulated gastrointestinal digestion (SGID) 
SGID was performed as described by Walsh et al. (2004) with modifications. In brief, the pH of the water 
and soup/juice products containing 2.0 % (w/v) hydrolysate was altered to pH 2.0 using 6M HCl and were 
then incubated at 37˚C for 90 min with pepsin at an E:S of 2.5% (w/w). The pH of the samples were then 
adjusted to pH 7.0 using 5N NaOH and incubated at 37˚C with Corolase PP (E:S of 1.0 % (w/w)) for a 
further 150 min. Enzyme activity was inactivated by heating at 80˚C for 20 min.
2.6. Peptide profile
The peptide profiles of the samples were determined by reverse-phase ultra-performance liquid 
chromatography (RP-UPLC) as described by  Nongonierma & FitzGerald (2012)  at a flow rate of 0.2 
ml/min.
2.7. Quantification of DPP- IV inhibitory activity
DPP-IV inhibition was determined as described by Harnedy et al. (2015). All assays were performed in 
triplicate (n=3). Activity results were expressed as % inhibition at a BPH concentration of 2 mg/ml. 
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2.8. Microbial analysis
Samples of fortified juice which underwent thermal treatment and were stored at 4˚C for 30 days, were 
diluted using Ringers solution and plated onto standard plate count agar (PCA) to determine the total 
plate count (TPC). The plates were incubated at 37˚C for 48 h and the colonies were then counted. 
2.9. Statistical analysis
All statistical analysis was performed using the SPSS statistical software program (Version 22, IBM Inc., 
Chicago, IL, USA). Statistical significance (p<0.05) was determined using one-way analysis of variance 
(ANOVA) followed by Tukey’s and Games–Howell post-hoc tests, where applicable. 
3.0 Results and Discussion
3.1 Selection of hydrolysate delivery vehicle and assessment of thermal heat treatment conditions 
The nature and type of food products that can act as delivery vehicles for biofunctional peptide 
ingredients depends to a large extent on the stability of the active peptides within the food matrix 
selected, the processing conditions employed and the stability of the peptides during storage. Two 
tomato-based products, a soup and juice which in general undergo pasteurisation and sterilisation 
treatments to enhance shelf-life, were selected as the delivery vehicles in this study. Selection of these 
formats was based on the following: (a) the savoury nature of the soup/juice could mask the odour/taste 
associated with the BPH, (b) the low glycaemic load (GL: 4 for V8® vegetable juice (Atkinson et al., 2008)) 
and negligible lipid content makes it suitable for delivery of a functional ingredient for glycaemic 
management and (c) its intrinsically low protein content (approximately 0.9 % (w/v)). The protein 
equivalent content of the BPH generated at semi-pilot scale used herein was 71.35 % (w/w). The quantity 
of hydrolysate incorporated into the soup and juice product in this study was based on the amount of 
hydrolysate powder (3.5g) which mediated an anti-diabetic response in vivo (Parthsarathy et al., 2019). 
Taking into account a typical serving of soup (60 ml) and juice (150 ml), the hydrolysate fortification level 
utilised was 5.83 and 2.33 % (w/v) for the soup and juice product, respectively. This in turn equates to a 
protein equivalent content of 4.16 and 1.64 % (w/v), respectively, and an overall dose of 2.50 and 2.46 g 
protein equivalent, respectively. The fortified tomato-based soup sample utilised in this study was the 
same as that used in a randomised controlled human intervention crossover study designed to assess the 
effect of hydrolysate intake (3.50 g) equivalent to 2.50 g protein on biomarkers of glycaemic control and 
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industry to inactivate microorganisms and enzymes and to thereby extend the shelf-life of food products.  
In the tomato processing industry, common conditions used for pasteurisation and sterilisation of tomato-
based products involve heating at 90o C x 1 min and 121 oC x 42 s, respectively (Gould, 1992). 
Furthermore, the recommended instructions for heating tomato-based soup products prior to 
consumption is to heat at 80o C x 3 min, however, the common practice of heating soup involves heating 
at 95o C x 3 min. Studies were therefore performed to determine if the routine thermal treatment 
conditions used in industry to preserve tomato-based products (soup and juice) and the suggested or 
actual conditions used to heat soup prior to consumption had an effect on the in vitro DPP-IV inhibitory 
activity and peptide profile of the BPH when incorporated into these delivery formats.
3.2 Effect of heat treatment on the DPP-IV inhibitory activity and peptide profiles of the boarfish 
hydrolysate when incorporated into tomato-based soup and juice products.
As shown in Tables 1 and 2, none of heat treatments employed/tested had any effect on the DPP-IV 
inhibitory activity of the aqueous BPH solutions. Furthermore, no differences were observed in the RP-
UPLC profiles of the aqueous hydrolysate solutions irrespective of whether they were subjected or not 
subjected to thermal treatment (data not shown). This indicates that the hydrolysate was thermostable 
and that the recommended pasteurization (90°C x 1 min) and the recommended and commonly used 
reheating conditions for soup (80o C x 3 min and 95o C x 3 min, respectively) and the sterilization (121°C x 
42 s) conditions employed had no effect on the hydrolysate peptide profile and the DPP-IV inhibitory 
activity. 
The results reported herein are consistent with the findings of Lai et al. (2016), who showed that walnut 
protein hydrolysates were stable and retained their antioxidant activity following heat treatment at 65°C x 
30 min and 121°C x 20 min. Furthermore, the bioactivity exhibited by rapeseed, tuna cooking juice and 
bovine casein-derived protein hydrolysate/peptides was reported to be stable when subjected to 
temperatures in the range 0-100 °C (Hwang, 2010; Wu et al., 2014; Wali et al., 2017). However, the 
angiotensin converting enzyme inhibitory activity mediated by the rapeseed and casein-derived protein 
hydrolysate/peptides significantly decreased when heated at temperatures above 100 °C. However, it 
should be noted that the duration of thermal treatment was 1 and 2 h, respectively (Wu et al., 2014; Wali 
et al., 2017).  Antioxidant peptides derived from Jinhua ham were shown to be less thermostable than the 
protein hydrolysate/peptides described above (Zhu et al., 2014). The ham peptides were shown to lose 
activity when heated above 60°C. 
A similar result to that observed with aqueous hydrolysate solutions herein was seen with the tomato-
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have no effect on the DPP-IV inhibitory activity (Table 1 and 2). As shown in Table 1 no significant 
difference (p>0.05) was observed in the in vitro DPP-IV inhibitory activity of the fortified soup samples 
which underwent no heat treatment (72.29 ± 1.18 %) or which were heated at 80 o C x 3 min (72.34 ± 1.71 
%), 95o C x 3 min (73.47 ± 2.97 %) and 121°C x 42 s (72.45 ± 2.66 %) when tested at 2 mg/ml. Similarly, no 
significant difference was observed in the DPP-IV inhibitory activity (Table 2) of the fortified juice samples 
which received no heat treatment (74.23 ± 2.56 %) or were treated at 90o C x 1 min (73.67 ± 4.39 %) and 
121°C x 42 s (72.74 ± 4.63 %). Similar RP-UPLC profiles were observed for the non-heat treated aqueous 
and tomato beverage samples containing the hydrolysate (data not shown). This indicates that there was 
no negative interaction between the tomato-based matrix and the hydrolysate. Furthermore, no 
differences were observed in the RP-UPLC profiles of the hydrolysate incorporated into soup and juice 
matrices pre- and post-heat treatment (Fig 1a and 2). This indicates that that there was no interaction 
between the tomato-based matrix and the hydrolysate during the heat treatments employed. This 
suggests that the biofunctional BPH is stable under the thermal conditions tested and could be 
incorporated into a tomato-based matrix and withstand the standard industrial thermal processing 
conditions required for the preservation and reheating of these commercially available products.
Food products commonly undergo heat treatment to improve their safety and/or extent their shelf-life 
(Rawson et al., 2011). Therefore, the effect of storage (4 °C for 30 days) on the bioactivity and the peptide 
profile of heat treated (90o C x 1 min and 121°C x 42 s) hydrolysate containing juice samples was assessed. 
A similar study with an aqueous suspension of the hydrolysate was performed for comparative purposes. 
Firstly, microbial analysis of the fortified juice samples which underwent pasteurisation and sterilisation 
and which was stored for 30 days at 4 °C shows that the heat treatments applied were effective in 
inhibiting the growth of potential spoilage organisms during the course of 30 days’ storage. The sterilised 
sample was free from bacteria, while the pasteurised sample had a total count of 400 cfu/ml at day 30, 
which is within the acceptable limits for human consumption (FSA, 2016). As shown in Table 2, the DPP-IV 
inhibitory activity of the aqueous solution did not change over the storage period assessed irrespective of 
the thermal treatment applied. Furthermore, the DPP-IV inhibitory activity exhibited by the juice product 
fortified with the hydrolysate also remained the same over the storage period assessed again irrespective 
of the thermal treatment applied. This indicates that the hydrolysate was stable over the storage period 
assessed (as seen with the aqueous hydrolysate solution) and that the juice vehicle had no negative effect 
on the in vitro anti-diabetic activity of the hydrolysates during storage. This was also seen following RP-
UPLC analysis of the samples where no difference was observed in the peptide profiles obtained for the 
thermally and non-thermally treated fortified juice samples stored for 30 days at 4 °C (Figure 2). Similar 
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Thiansilakul et al. (2007) showed that the hydrolysate retained its antioxidant activity during the storage 
period. While a small decrease in DPPH radical-scavenging activity was observed within the first week of 
storage at 4 and 25 °C, no further change in DPPH radical-scavenging activity was observed thereafter. No 
significant difference in the reducing power or the metal-chelating activity of the protein hydrolysate was 
observed within the first 2 weeks of storage at 4 and 25 °C, however, a slight decrease in activity was 
observed between weeks 2-6. It was shown that the antioxidant activity exhibited by the round scad 
protein hydrolysate was more stable when stored at 4 than at 25 °C (Thiansilakul et al., 2007).  Milk 
protein derived antihypertensive peptides, RYLGY and AYFYPEL, were also shown to be stable when 
incorporated into a yoghurt product and stored at 4 °C for 28 days (Contreras et al., 2011). 
While the storage temperature selected in this study (4 °C) represents that commonly utilised for a 
pasteurised product, a sterilised product would usually be stored at room temperature and for a longer 
period of time (>30 days). It would be interesting to investigate if the sterilised hydrolysate containing 
product could retain their activity following storage at ambient temperature for extended periods of 
storage. 
3.3 Effect of SGID on the DPP-IV inhibitory activity and RP-UPLC profiles of a boarfish hydrolysate when 
incorporated into tomato-based soup and juice products 
In order to exert a biological effect in vivo, the integrity of active peptides within the food vehicle must be 
maintained during digestion and transport. In a previous study we have shown that the BPH was resistant 
to SGID (Harnedy-Rothwell et al., 2020). This was also observed herein in Table 1 where no significant 
differences (P>0.05) were observed in the DPP-IV inhibitory activity by the non-heat treated aqueous 
hydrolysate samples pre- and post-SGID. 
As shown in Table 1 and 2, no significant differences (P>0.05) were observed in the DPP-IV inhibitory 
activity pre- and post-SGID for the non-heat and heat-treated soup and juice samples containing the 
hydrolysate.  The fact that similar DPP-IV inhibitory activity and peptide profiles were observed for the 
non-heat treated soup and juice samples before and after SGID (Tables 1 and 2, Figures 1, 2 and 3) 
indicates that components within the tomato-based vehicles did not alter the hydrolysate’s resistance to 
SGID. Furthermore, similar results were seen with the heat treated soup and juice samples, which would 
indicate that the heat treatments employed had no effect on the in vitro digestion status of the 
hydrolysate (Tables 1 and 2, Figures 1, 2 and 3). 
To our knowledge there is no information available on the effect of food formulation and processing on 
the SGID status of foods containing protein hydrolysates. However, it is possible that the bioactivity of 
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conditions may be improved or reduced following SGID. Modifications to peptide structure induced 
during processing may alter the digestibility of the peptides producing breakdown products which may be 
more or less potent than the original peptides. Furthermore, peptides that would otherwise be rendered 
inactive by exposure to the SGID enzymes when taken in aqueous format may be protected when 
incorporated in a food matrix. However, in vivo investigations would be required to confirm the 
observations herein.
4. Conclusion
This study has shown that the thermal processing and storage conditions used routinely to enhance the 
shelf-life of tomato-based juice and soup products had no effect on the in vitro anti-diabetic activity and 
peptide profile of a BPH incorporated therein. Furthermore, the tomato-based juice and soup vehicles and 
the processing and storage conditions assessed had no effect on the SGID status of the BPH. Therefore, 
the present study highlights the potential of tomato-based products as vehicles for delivery of protein 
hydrolysates. While preliminary sensory analyses performed prior to the human study indicated that the 
savoury flavour of the tomato-based chilli soup had the ability to mask the fishy taste/odour of the BPH 
within, comprehensive organoleptic and acceptability studies need to be performed to ensure that the 
fortified products are accepted by a broad range of consumers.  It must also be noted that while the 
tomato-based beverages used herein had low glycaemic loads, in general, commercially produced tomato 
soup can contain sugar which would add significantly to the glycaemic load and render it unsuitable as a 
delivery vehicle for antidiabetic agents. Furthermore, fortification of foods with the BPH presents a 
unique opportunity to increase the commercial value of a low-value underutilised fish species through the 
production of nutritionally and biofunctionally enriched beverage products.
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Table 1. Impact of different thermal treatments and simulated gastrointestinal digestion (SGID) on 
the dipeptidyl peptidase-IV (DPP-IV) inhibitory activity of a boarfish (Capros aper) protein 
hydrolysate (BPH) in an aqueous and soup matrix. 
 
Sample Heat treatment DPP-IV inhibition (%) 





None 63.27 ± 1.18
a





C  x 3 min 62.13 ± 1.96
a





C  x 3 min 63.72 ± 2.39
a





C x  42 s 61.56 ± 1.02
a 61.68 ± 1.71a* 
BPH + Soup 
 
None 72.79 ± 1.18
a





C  x 3 min 72.34 ± 1.71
a





C x 3 min 73.47 ± 2.97
a





C x  42 s 72.45 ± 2.66





















C  x 42 s 10.01 ± 1.04
a nd 
Mean ± SD (n=3). The concentration of hydrolysate used in all cases was 2 mg/ml. For each sample 
values with different letters are significantly different at p<0.05. *: indicates that no significant 
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Table 2. Impact of heat treatment, storage time and simulated gastrointestinal digestion (SGID) on 
the dipeptidyl peptidase-IV (DPP-IV) inhibitory activity of a boarfish (Capros aper) protein 
hydrolysate (BPH) in an aqueous and tomato-based juice matrix. 
 
Sample Heat treatment  Storage time 
(Days) 
DPP-IV inhibition (%) 
   Before SGID After SGID 
BPH + H2O  
 
None  0 61.72 ± 2.47a 66.66 ± 2.71a* 
90 
o
C x 1 min  0 63.05 ± 3.71
a 67.59 ± 1.06a* 
90 
o
C x 1 min  15 62.49 ± 3.60
a 64.81 ± 1.49a* 
90 
o
C x 1 min  30 64.21 ± 1.56
a 66.58 ± 1.94a* 
121 
o
C x 42 s  0 62.80 ± 1.44
a 64.26 ± 1.72a* 
121 
o
C x 42 s  15 63.00 ± 2.39
a 66.98 ± 0.63a* 
121 
o
C x 42 s  30 62.09 ± 3.61
a 66.30 ± 0.34a* 
BPH + Juice   
 
None  0 74.23 ± 2.56a 80.34 ± 3.03a* 
90 
o
C x 1 min  0 73.67 ± 4.39
a 76.23 ± 1.25a* 
90 
o
C x 1 min  15 73.93 ± 2.52
a 76.46 ± 1.91a* 
90 
o
C x 1 min  30 74.40 ± 2.85
a 77.58 ± 1.85a* 
121 
o
C x 42 s  0 72.74 ± 4.63
a 75.03 ± 1.60a* 
121 
o
C x 42 s  15 74.49 ± 4.08
a 75.73 ± 2.38a* 
121 
o
C x 42 s  30 75.56 ± 3.21
a 80.39 ± 1.91a* 
Juice + H2O 
 
None  0 31.46 ± 0.42a nd 
90 
o




















C x 42 s  30 29.85 ± 3.16
a nd 
Mean ± SD (n=3), The concentration of hydrolysate used in all cases was 2 mg/ml. For each sample 
values with different letters are significantly different p<0.05. *: indicates that no significant 
















Fig. 1. Reverse-phase ultra-performance liquid chromatography profiles of soup samples fortified with a boarfish (Capros aper) protein hydrolysate (5.83 % 5 






















Fig. 2. Reverse-phase ultra-performance liquid chromatography profiles of juice samples containing 15 
a boarfish (Capros aper) protein hydrolysate (2.33% (w/v)) following two different heat treatments 16 
(90 
o
C x 1 min and 121 
o
C x 42 s) and subsequent storage at 4 
o
C. Control: No heat treatment, D0: 17 






























Fig. 3. Reverse-phase ultra-performance liquid chromatography profiles of juice samples containing 36 
a boarfish (Capros aper) protein hydrolysate (2.33% (w/v)) before and after simulated 37 
gastrointestinal digestion (SGID) following different heat treatments (a) 90 
o
C x 1 min and (b) 121 
o
C 38 
x 42 s and subsequent storage at 4 
o
C for 15 (D15) and 30 (D30) days.  39 
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